Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina

Abroad (travel likely)RecruitingPHASE2

Conditions

Refractory Angina Pectoris · Refractory Angina

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

St Bartholomew's Hospital, London, England, United Kingdom
Contact: Study coordinator (R&D Governance Administrator) · research.governance@qmul.ac.uk · +44 (0)20 7882 6826
Contact: Study coordinator (Ruth Bowles) · r.bowles@qmul.ac.uk · +44 (0) 20 3765 8704
Contact: Principal Investigator (Anthony Mathur)

Study leads

Anthony Mathur
Principal Investigator
Barts & The London NHS Trust

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

Refractory Angina · Coronary Artery Disease

Abroad (travel likely)RecruitingPHASE2

Cincinnati, United States

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Refractory Angina

Abroad (travel likely)Recruiting

Phoenix, United States · Scottsdale, United States

Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.

Refractory Angina · Microvascular Angina · Microvascular Coronary Artery Disease

Abroad (travel likely)Recruiting

London, United Kingdom

COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina

Coronary Microvascular Disease · Refractory Angina

Abroad (travel likely)Recruiting

Mainz, Germany